Head of Corporate Strategy and Commercial Development
As a biotechnology professional with 14 years of industry experience, Brett has held positions in commercial, corporate and business development, corporate strategy, and strategic operations functions. In his current role, Brett leads all corporate strategy initiatives and develops commercial strategies for HOST’s lead drug development programs.
Prior to joining HOST Therabiomics, he worked as Director of Commercial Assessment at Shire where he was responsible for performing commercial due diligence for licensing, mergers and acquisitions, and aligning immunology and neuroscience disease area strategies with the broader corporate strategy. Before working at Shire, Brett held roles of increasing responsibility at Biogen and Sanofi.
Brett holds a B.A. in English and Psychology from Amherst College and an MBA from the Boston University Questrom School of Business.